Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (131-140 of 353) with videos related to

Pageof 36
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2013
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trialsTobias Geisler, Karin Müller, Athanasios Karathanos, et al.
Archives of Internal Medicine|November 26, 2003
In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysisHerbert D Aronow, Gian M Novaro, Michael S Lauer, et al.
JAMA Cardiology|March 7, 2019
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 TrialPreethi Mani, Rishi Puri, Gregory G Schwartz, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2025
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes TrialStephen J Nicholls, Kausik K Ray, A Michael Lincoff, et al.
Clinical Cardiology|April 2, 2026
Sex Differences in Statin Intolerance: Insights From the CLEAR Outcomes TrialSahar Naderi, Danielle Brennan, Na Li, et al.
American Heart Journal|January 6, 2005
Impact of female sex on outcome after percutaneous coronary interventionJohn H Chiu, Deepak L Bhatt, Khaled M Ziada, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 2005
Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injuryKai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
The American Journal of Cardiology|March 11, 2005
Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical centerHitinder S Gurm, Vivek Rajagopal, Robert Fathi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2005
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeGlenn N Levine, A Michael Lincoff, James J Ferguson, et al.
JAMA Cardiology|January 17, 2024
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical TrialStephen J Nicholls, Adam J Nelson, A Michael Lincoff, et al.
Pageof 36

Showing results (131-140 of 353) with videos related to

Sort By:
Pageof 36
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2013
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trialsTobias Geisler, Karin Müller, Athanasios Karathanos, et al.
Archives of Internal Medicine|November 26, 2003
In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysisHerbert D Aronow, Gian M Novaro, Michael S Lauer, et al.
JAMA Cardiology|March 7, 2019
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 TrialPreethi Mani, Rishi Puri, Gregory G Schwartz, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2025
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes TrialStephen J Nicholls, Kausik K Ray, A Michael Lincoff, et al.
Clinical Cardiology|April 2, 2026
Sex Differences in Statin Intolerance: Insights From the CLEAR Outcomes TrialSahar Naderi, Danielle Brennan, Na Li, et al.
American Heart Journal|January 6, 2005
Impact of female sex on outcome after percutaneous coronary interventionJohn H Chiu, Deepak L Bhatt, Khaled M Ziada, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 2005
Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injuryKai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
The American Journal of Cardiology|March 11, 2005
Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical centerHitinder S Gurm, Vivek Rajagopal, Robert Fathi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2005
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeGlenn N Levine, A Michael Lincoff, James J Ferguson, et al.
JAMA Cardiology|January 17, 2024
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical TrialStephen J Nicholls, Adam J Nelson, A Michael Lincoff, et al.
Pageof 36